GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Imricor Medical Systems Inc (ASX:IMR) » Definitions » EV-to-FCF

Imricor Medical Systems (ASX:IMR) EV-to-FCF : -19.95 (As of Mar. 30, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Imricor Medical Systems EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Imricor Medical Systems's Enterprise Value is A$481.24 Mil. Imricor Medical Systems's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was A$-24.13 Mil. Therefore, Imricor Medical Systems's EV-to-FCF for today is -19.95.

The historical rank and industry rank for Imricor Medical Systems's EV-to-FCF or its related term are showing as below:

ASX:IMR' s EV-to-FCF Range Over the Past 10 Years
Min: -19.95   Med: -5.09   Max: 0.33
Current: -19.95

During the past 7 years, the highest EV-to-FCF of Imricor Medical Systems was 0.33. The lowest was -19.95. And the median was -5.09.

ASX:IMR's EV-to-FCF is ranked worse than
100% of 384 companies
in the Medical Devices & Instruments industry
Industry Median: 26.5 vs ASX:IMR: -19.95

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-30), Imricor Medical Systems's stock price is A$1.475. Imricor Medical Systems's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.202. Therefore, Imricor Medical Systems's PE Ratio (TTM) for today is At Loss.


Imricor Medical Systems EV-to-FCF Historical Data

The historical data trend for Imricor Medical Systems's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imricor Medical Systems EV-to-FCF Chart

Imricor Medical Systems Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial -13.30 -4.76 -2.15 -5.67 -15.22

Imricor Medical Systems Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.15 - -5.67 - -15.22

Competitive Comparison of Imricor Medical Systems's EV-to-FCF

For the Medical Devices subindustry, Imricor Medical Systems's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Imricor Medical Systems's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Imricor Medical Systems's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Imricor Medical Systems's EV-to-FCF falls into.


;
;

Imricor Medical Systems EV-to-FCF Calculation

Imricor Medical Systems's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=481.239/-24.127
=-19.95

Imricor Medical Systems's current Enterprise Value is A$481.24 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Imricor Medical Systems's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was A$-24.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Imricor Medical Systems  (ASX:IMR) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Imricor Medical Systems's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.475/-0.202
=At Loss

Imricor Medical Systems's share price for today is A$1.475.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Imricor Medical Systems's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.202.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Imricor Medical Systems EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Imricor Medical Systems's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Imricor Medical Systems Business Description

Traded in Other Exchanges
N/A
Address
400 Gateway Boulevard, Burnsville, MN, USA, 55337
Imricor Medical Systems Inc is a medical device company engaged in addressing issues with traditional x-ray-guided ablation procedures through the development of MRI-guided technology. Its principal business activities are to design, manufacture and sell MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. The products of the company include Advantage-MR EP Recorder/Stimulator, Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode.

Imricor Medical Systems Headlines

No Headlines